Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com

Stock Price vs Company Growth
1d
2.7%
1w
4.4%
1m
12.1%
3m
30.7%
6m
82.3%
1y
140.4%
5y
24.7%
10y
13.0%
all
19.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 911 2.7%
697
960
Company Overview

Sales
1,214 Cr
Growth: 8.2%
Profit after Tax
55 Cr
Growth: 42.3%
Mid Cap
8,909 Cr
P/E: 137.2x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 1,214
Growth 8.2%
EBITDA 24.3%
P/S 7.3x
Dividend 0.0%
P/E 137.2x
Book Value ₹ 188
PEG Ratio 16.6x
ROE 3.0%
P/B 4.8x
Shareholding Pattern

Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed

Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Investors (146)
Followers (7)